Smasher: starting new info...

2026-04-03T13:33:28Z

starting new info...

New page

{{Short description|Indian healthcare entrepreneur}}
{{Orphan|date=February 2026}}
{{Infobox person
| name = Gomathy Babu Sadacharam Kulandaivelu
| image = Gomathy Babu Sadacharam Kulandaivelu.jpg
| birth_name =
| birth_place = Aralvaimozhy, Kanyakumari district, Tamil Nadu, India
| alma_mater = {{ubl|[[BITS Pilani]] (B.Pharm)|[[Loyola Institute of Business Administration|LIBA]] (MBA)}}
| occupation = Healthcare entrepreneur, business executive
| title = [[Consul (representative)|Honorary Consul]] of the [[Republic of Estonia]]
| awards =
}}

'''Gomathy Babu Sadacharam Kulandaivelu Velu'''<ref>{{Cite web |date=2021-11-27 |title=Välisministeerium tunnustab kodanikupäeval rahvadiplomaate |url=https://kesknadal.ee/2021/11/27/valisministeerium-tunnustab-kodanikupaeval-rahvadiplomaate/ |access-date=2026-01-13 |website=Kesknädal |language=et}}</ref> (also known as G. S. K. Velu) is an Indian healthcare entrepreneur.<ref>{{Cite web |last=Chaki |first=Deborshi |date=5 April 2017 |title=India: Carlyle threatens legal action against healthcare entrepreneur G.S.K. Velu |url=https://www.dealstreetasia.com/stories/carlyle-threatens-legal-action-against-g-s-k-velu-69546 |access-date=2026-01-13 |website=[[DealStreetAsia]] |language=en}}</ref><ref>{{Cite news |last=Shah |first=Sneha |date=2017-12-14 |title=Entrepreneur Velu back in diagnostics |url=https://economictimes.indiatimes.com/small-biz/startups/newsbuzz/entrepreneur-velu-back-in-diagnostics/articleshow/62063317.cms?from=mdr |access-date=2026-01-13 |work=The Economic Times |issn=0013-0389}}</ref> He is the founder of Trivitron Healthcare and Neuberg Diagnostics, companies operating in the medical technology and diagnostics sectors in India and abroad.<ref>{{Cite news |date=2016-07-12 |title=Healthcare entrepreneur GSK Velu to start food testing company |url=https://timesofindia.indiatimes.com/city/bengaluru/healthcare-entrepreneur-gsk-velu-to-start-food-testing-company/articleshow/53177421.cms |access-date=2026-01-13 |work=The Times of India |issn=0971-8257}}</ref>

== Early life and education ==
Velu was born in Aralvaimozhy, [[Kanyakumari district]], Tamil Nadu.<ref name=":4">{{Cite book |last=Mandlecha |first=Gaurav |url=https://www.google.co.in/books/edition/The_Pilani_Pioneers_Inspiring_Success_St/whU5EAAAQBAJ?hl=en&gbpv=1&dq=%22GSK+Velu%22+-wikipedia&pg=PT56&printsec=frontcover |title=The Pilani Pioneers: Inspiring Success Stories of 25 BITS Pilani Graduates |last2=Sethi |first2=Durjai |date=2021-08-03 |publisher=Pan Macmillan |isbn=978-81-949707-8-1 |language=en}}</ref><ref name=":0">{{Cite news |last=Govardan |first=D |date=2022-05-16 |title=Life gave him tests, he made a career out of it |url=https://timesofindia.indiatimes.com/business/india-business/life-gave-him-tests-he-made-a-career-out-of-it/articleshow/91056928.cms |access-date=2026-01-13 |work=The Times of India |issn=0971-8257}}</ref> He attended a Tamil‑medium school near [[Madurai]] before earning a pharmacy degree from [[BITS Pilani]] in 1988<ref name=":1">{{Cite news |last=Gupta |first=Aparajita |date=2011-10-06 |title=Equipped To Succeed |url=https://timesofindia.indiatimes.com/business/india-business/equipped-to-succeed/articleshow/10251831.cms |access-date=2026-01-13 |work=The Times of India |issn=0971-8257}}</ref> and an MBA from [[Loyola Institute of Business Administration]], Chennai. He later completed doctoral studies in pharmacology at IBAM, Kolkata,<ref name=":22">{{Cite web |last=Bose |first=Sajal |date=2023-09-22 |title=Neuberg's healthy growth |url=https://businessindia.co/magazine/corporate-report/neubergs-healthy-growth |access-date=2026-01-13 |website=Business India |language=en}}</ref> and was later awarded an honorary doctorate by [[Vels Institute of Science, Technology & Advanced Studies|Vel's University]].<ref name=":1" /><ref name=":4" />

== Career ==
Velu began his career in the medical devices and diagnostics sector in the late 1980s, working in technical and regional roles with companies involved in medical equipment and laboratory diagnostics in India and [[Southeast Asia]].<ref name=":1" />

In 1997, he founded Trivitron Healthcare in [[Chennai]].<ref name=":1" /><ref>{{Cite web |title=Metropolis founder Velu in talks with PEs for stake sale |url=https://www.business-standard.com/article/companies/metropolis-founder-velu-in-talks-with-pes-for-stake-sale-115042800046_1.html}}</ref> The company initially operated as a distributor for international medical equipment brands before moving into manufacturing.<ref name=":0" /><ref>{{Cite news |last=Julka |first=Harsimran |last2=Abrar |first2=Peerzada |date=2013-02-08 |title=India spawning top notch medical devices companies with cutting-edge tech at affordable prices |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/india-spawning-top-notch-medical-devices-companies-with-cutting-edge-tech-at-affordable-prices/articleshow/18392746.cms?from=mdr |access-date=2026-01-02 |work=The Economic Times |issn=0013-0389}}</ref> In the mid-2010s, Trivitron established a medical technology park in Chennai as part of its manufacturing expansion.<ref>{{Cite book |last=Kannan-Narasimhan |first=Rangapriya |url=https://sk.sagepub.com/cases/embed/trivitron-india-born-global-moving-up-value-chain-investing-people |title=Trivitron's India-Born Global Story: Moving Up the Value Chain by Investing in the Power of People |last2=Arcodia |first2=Antonio |last3=Patnaik Bhogela |first3=Lokapati |last4=Siddalinga Swamy |first4=Prakruti |last5=Syed |first5=Jennifer |date= |publisher=SAGE Publications: SAGE Business Cases Originals |isbn=978-1-5297-4066-0 |location=1 Oliver's Yard, 55 City Road, London EC1Y 1SP United Kingdom |language=en |doi=10.4135/9781529740660}}</ref><ref>{{Cite news |date=2009-04-22 |title=Trivitron, BioSystems, Spain to set up facility in Chennai |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/trivitron-biosystems-spain-to-set-up-facility-in-chennai/articleshow/4436645.cms?from=mdr |access-date=2026-01-05 |work=The Economic Times |issn=0013-0389}}</ref>

In 1999 Velu acquired a 50% stake in a pathology laboratory business in [[Mumbai]], which was later corporatized as [[Metropolis Healthcare]].<ref name="Mint_Tussle2">{{cite news |last1=Lall |first1=Priti |date=2016-01-19 |title=How Ameera Shah took control of the Metropolis diagnostics chain |url=https://www.livemint.com/Companies/txyYMg7XcC9rUVXMZyiGlI/How-Ameera-Shah-took-control-of-the-Metropolis-diagnostics-c.html |access-date=2026-01-13 |newspaper=Mint}}</ref> His family retained a significant minority shareholding alongside the founding promoters and financial investors.<ref>{{Cite web |title=Trivitron and the Impending Rise of Medical Technology |url=https://www.forbesindia.com/article/big-bet/trivitron-and-the-impending-rise-of-medical-technology/35461/1 |access-date=2026-01-13 |website=www.forbesindia.com |language=en}}</ref><ref>{{Cite web |date=2015-01-14 |title=Metropolis promoter rules out stake sale in near future - BusinessToday |url=https://www.businesstoday.in/latest/corporate/story/metropolis-promoter-gsk-velu-rules-out-stake-sale-in-near-future-144212-2015-01-14 |access-date=2026-01-13 |website=Business Today |language=en}}</ref> He exited the company in 2015 by selling his remaining stake to private equity firm [[The Carlyle Group]], following a shareholder dispute relating to management control and [[Stock dilution|stake dilution]].<ref name="VCC_NonCompete2">{{cite web |date=2017-04-05 |title=Carlyle may lock horns with health entrepreneur GSK Velu over non-compete clause |url=https://www.vccircle.com/carlyle-may-lock-horns-with-health-entrepreneur-gsk-velu-over-non-compete-clause |access-date=2026-01-13 |website=VCCircle}}</ref><ref>{{Cite web |date=9 September 2015 |title=Carlyle Group unit buys stake in India lab operator Metropolis Healthcare |url=https://www.reuters.com/article/business/carlyle-group-unit-buys-stake-in-india-lab-operator-metropolis-healthcare-idUSL4N11F3QJ/ |access-date=2026-01-13 |website=Reuters}}</ref><ref>{{Cite web |last=Tudor-Ackroyd |first=Alison |date= |title=Carlyle ends boardroom spat at India's Metropolis |url=https://www.financeasia.com/article/carlyle-ends-boardroom-spat-at-indias-metropolis/401732 |access-date=2026-01-11 |website=FinanceAsia}}</ref>

=== Neuberg Diagnostics ===
In 2017, Velu re-entered the diagnostic sector by founding Neuberg Diagnostics,<ref name="VCC_Gameplan2">{{cite web |date=2017-12-14 |title=GSK Velu's game plan in diagnostics business after Metropolis exit |url=https://www.vccircle.com/gsk-velus-game-plan-in-diagnostics-biz-despite-legal-tussle-with-metropolis |access-date=2026-01-13 |website=VCCircle}}</ref><ref>{{Cite web |last=Hariharan |first=Sindhu |date=2025-11-03 |title=Healthcare entrepreneur GSK Velu preparing firms for public listing |url=https://www.thehindubusinessline.com/companies/healthcare-entrepreneur-gsk-velu-preparing-firms-for-public-listing/article70232879.ece |access-date=2026-01-13 |website=BusinessLine |language=en}}</ref> an alliance of pathology laboratories operating across India and selected international markets.<ref>{{Cite web |title=Bottomline: Can GSK Velu's Neuberg Diagnostics sustain its acquisition-led growth? |url=https://www.vccircle.com/bottomlinecangsk-velu-s-neuberg-diagnostics-sustain-its-acquisition-led-growth |access-date=2026-01-13 |website=VCCircle |language=en-US}}</ref> By the mid-2020s, Neuberg Diagnostics had established laboratory operations in India, the United Arab Emirates, and South Africa.<ref name=":22"/><ref>{{Cite web |last=Babu |first=Gireesh |date=6 September 2019 |title=Serial entrepreneur G S K Velu to ramp up diagnostics biz in west and south |url=https://www.business-standard.com/article/companies/serial-entrepreneur-g-s-k-velu-to-ramp-up-diagnostics-biz-in-west-and-south-119090600778_1.html |access-date=2026-01-13 |website=BusinessStandard}}</ref><ref>{{Cite web |last=Sanjay |first=Satviki |date=11 November 2025 |title=Neuberg Diagnostics Said to Eye $350 Million India IPO in 2026 |url=https://www.bloomberg.com/news/articles/2025-11-11/india-s-neuberg-diagnostics-said-to-eye-350-million-ipo-in-2026 |access-date=2026-01-13 |website=Bloomberg}}</ref>

=== Maxivision Eye Hospitals and other ventures ===
Velu partnered with ophthalmologist Kasu Prasad Reddy in the expansion of Maxivision Eye Hospitals, which operates a network of specialty eye hospitals and clinics across multiple regions in India.<ref>{{Cite news |date=2025-02-14 |title=Maxivision Group invests in Ojas Group to expand eye hospital network in Maharashtra |url=https://www.thehindu.com/business/maxivision-group-invests-in-ojas-group-to-expand-eye-hospital-network-in-maharashtra/article69219983.ece |access-date=2026-01-13 |work=The Hindu |language=en-IN |issn=0971-751X}}</ref><ref>{{Cite web |last=Balakrishnan |first=Reghu |date= |title=G.S.K. Velu's eye care chain seeks Rs200 crore funds |url=https://www.livemint.com/Companies/KniCxd4L72ZE2LCs3zC1GP/GSK-Velus-eye-care-chain-seeks-Rs200-crore-funds.html |access-date=2026-01-13 |website=mint |language=en}}</ref> In 2016, Velu invested in Kauvery Hospital, a Chennai-based hospital chain, where he holds a minority stake and serves on the board of directors. The group operates hospitals across [[Tamil Nadu]] and [[Karnataka]].<ref name=":3">{{Cite news |date=2022-01-28 |title=GSK Velu is FICCI T.N. Chair |url=https://www.thehindu.com/news/national/tamil-nadu/gsk-velu-is-ficci-tn-chair/article38341350.ece |access-date=2026-01-13 |work=The Hindu |language=en-IN |issn=0971-751X}}</ref> He has also entered into joint venture arrangements with Apollo Hospitals, resulting in minority shareholdings in Apollo Dialysis Clinics and Apollo Dental Ventures, which operate specialty dialysis and dental clinic networks in India.<ref>{{Cite web |last=P |first=Suraksha |date=2019-08-14 |title=Neuberg and GSK Velu's path(lab) to diagnostics redemption |url=https://the-ken.com/story/neuberg-and-gsk-velus-pathlab-to-diagnostics-redemption/ |access-date=2026-01-13 |website=The Ken |language=en-US}}</ref>

== Public and diplomatic roles ==
Velu has been active in industry advocacy, serving as the chairperson of the Tamil Nadu State Council for the [[Federation of Indian Chambers of Commerce & Industry]] (FICCI) in 2021.<ref>{{Cite journal |last=Revathi |first=J. |last2=Rani |first2=S. Jansi |date=2019-04-01 |title=Analysis of Factors Influencing Medical Tourism in India Chennai and its Impacts. |url=https://openurl.ebsco.com/contentitem/doi:10.5958%2F0976-5506.2019.00674.0?sid=ebsco:plink:crawler&id=ebsco:doi:10.5958%2F0976-5506.2019.00674.0 |journal=Indian Journal of Public Health Research & Development |language=en |volume=10 |issue=4 |pages=113 |doi=10.5958/0976-5506.2019.00674.0 |issn=0976-0245|doi-access=free }}</ref> In 2023, he was appointed as the Honorary Consul of the [[Estonia|Republic of Estonia]] for the [[South India]]n states of [[Tamil Nadu]], [[Kerala]], [[Andhra Pradesh]], and [[Telangana]].<ref name=":3" />

== Awards and recognition ==
In 2017, Velu received the Industry Achievement Award in Medical Technology from Hurun Report India.<ref>{{Cite news |date=2020-02-18 |title=Zoho, Pothys and Hatsun Agro appear on IIFL Wealth Hurun India Rich List 2019 |url=https://timesofindia.indiatimes.com/business/india-business/zoho-pothys-and-hatsun-agro-appear-on-iifl-wealth-hurun-india-rich-list-2019/articleshow/74195755.cms |access-date=2026-01-13 |work=The Times of India |issn=0971-8257}}</ref> He was later conferred the [[Ministry of Defence (Estonia)#Awards conferred by Ministry of Defence|Cross of Merit]] by the [[Estonia|Republic of Estonia]] for contributions to bilateral engagement.<ref>{{Cite web |title=Foreign Minister awards Crosses of Merit for contributions to Estonian statehood and foreign policy {{!}} Välisministeerium |url=https://www.vm.ee/en/news/foreign-minister-awards-crosses-merit-contributions-estonian-statehood-and-foreign-policy |access-date=2026-01-13 |website=www.vm.ee |language=en}}</ref><ref>{{cite web |date=9 November 2022 |title=Foreign minister honors contributions to Estonian statehood, foreign policy |url=https://news.err.ee/1608782863/foreign-minister-honors-contributions-to-estonian-statehood-foreign-policy |access-date=2026-01-13 |website=ERR |language=en}}</ref> In 2024, he received an honorary doctorate from [[Vels Institute of Science, Technology & Advanced Studies|VISTAS]].<ref>{{Cite news |date=2024-04-13 |title=Ram Charan awarded honorary doctorate in literature from Vels University |url=https://www.thehindu.com/entertainment/movies/ram-charan-awarded-honorary-doctorate-in-literature-from-vels-university/article68061679.ece |access-date=2026-01-13 |work=The Hindu |language=en-IN |issn=0971-751X}}</ref>

== Challenges and controversies ==

=== Metropolis Healthcare boardroom dispute ===
In 2015, a public boardroom dispute arose between Velu and the Shah family, in which Velu held a stake. The dispute followed a transaction in which the Shah family, led by managing director [[Ameera Shah]], increased their stake from 36% to 63% by purchasing the 27% shareholding held by private equity firm [[Warburg Pincus]], resulting in a shift in management control.<ref>{{Cite web |last=www.ETHealthworld.com |title=Metropolis boardroom becomes a battleground: Warburg Pincus' stake sale to Shahs irks partner Velu |url=http://health.economictimes.indiatimes.com/news/pharma/metropolis-boardroom-becomes-a-battleground-warburg-pincus-stake-sale-to-shahs-irks-partner-velu/46982378 |access-date=2026-01-13 |website=ETHealthworld.com {{!}} Pharma |language=en}}</ref><ref name="Mint_Tussle2" /> Velu alleged that the transaction had been carried out without adequate consultation and that his rights as a co-promoter had been bypassed.<ref name="TOI_Feud2">{{cite news |last1=Kurian |first1=Boby |last2=Ramalingam |first2=Aparna |date=2015-07-02 |title=Carlyle may end Metropolis feud with Rs 900cr stake buy |url=https://timesofindia.indiatimes.com/business/india-business/carlyle-may-end-metropolis-feud-with-rs-900cr-stake-buy/articleshow/47903004.cms |access-date=2026-01-02 |newspaper=The Times of India}}</ref>

In September 2015, the matter concluded when Velu divested his remaining stake in [[Metropolis Healthcare]] to private equity firm [[The Carlyle Group]] for an estimated ₹850–900 crore, marking his exit from the company.<ref>{{Cite web |title=Carlyle buys GSK Velu's stake in pathology chain Metropolis |url=https://www.vccircle.com/carlyle-buys-gsk-velus-stake-pathology-chain-metropolis |access-date=2026-01-13 |website=VCCircle |language=en-US}}</ref><ref name="Mint_Tussle2" />

=== Non-compete allegations ===
In 2017, [[The Carlyle Group]] issued a notice to Velu concerning potential breach of a non-compete agreement associated with Velu's 2015 exit from [[Metropolis Healthcare]].<ref name="VCC_NonCompete2"/><ref>{{Cite web |last=Chaki |first=Deborshi |date= |title=Carlyle threatens legal action against G.S.K. Velu |url=https://www.livemint.com/Companies/22IxGwQVyDaDDgA3O1xEdL/Carlyle-threatens-legal-action-against-GSK-Velu.html |access-date=2026-01-13 |website=mint |language=en}}</ref> The concerns were linked to his subsequent investments in the diagnostics sector through Neuberg Diagnostics. Velu denied any contractual violation, stating that he had complied with the terms of his exit agreement and that no legal proceedings were pending at the time.<ref name="VCC_Gameplan2"/>

== References ==
{{reflist}}

[[Category:Living people]]
[[Category:Indian businesspeople]]
[[Category:People from Kanyakumari district]]
[[Category:Businesspeople from Tamil Nadu]]
[[Category:Indian expatriates]]
[[Category:Honorary consuls]]
[[Category:Birla Institute of Technology and Science, Pilani alumni]]
[[Category:Year of birth missing (living people)]]

Gomathy Babu Sadacharam Kulandaivelu - Revision history

Smasher: starting new info...